Swissmedic has issued a batch recall notice for Benocten Tropfen zum Einnehmen Lösung, a product used in healthcare settings. The affected batches, including 210013, 210023, 210014, 210024, and 2100125, have been recalled from the market down to the retail level. This recall is crucial for ensuring patient safety and preventing potential health risks associated with the affected product.
What happened?
The batches of Benocten Tropfen zum Einnehmen Lösung subject to this recall have been identified and isolated from the market to prevent any potential harm. Swissmedic has taken swift action to notify the relevant stakeholders and ensure public awareness about the potential risks associated with the affected batches.
Key findings
Reasons behind the recall
The specific reason for this recall has not been disclosed by Swissmedic. However, the regulatory agency has emphasized the importance of taking preventative measures to protect public health and ensure the quality and safety of medicinal products.
Affected batches
The recalled batches of Benocten Tropfen zum Einnehmen Lösung are:
- 210013
- 210023
- 210014
- 210024
- 2100125
Next steps
Swissmedic is urging healthcare professionals and the public to report any incidents related to the use of the recalled batches. The regulatory agency will continue to monitor the situation and provide updates as more information becomes available.
Frequently Asked Questions
- What is the reason for the recall of Benocten Tropfen zum Einnehmen Lösung?
Swissmedic has not disclosed the specific reason for the recall. However, the regulatory agency is prioritizing the safety and quality of medicinal products.
- How can I identify the recalled batches of Benocten Tropfen zum Einnehmen Lösung?
The recalled batches have the following numbers: 210013, 210023, 210014, 210024, and 2100125.
- What should I do if I have used the recalled batches of Benocten Tropfen zum Einnehmen Lösung?
If you have used the recalled batches, please report any incidents to Swissmedic and consult a healthcare professional if you experience any adverse reactions.
Recall implications and conclusions
The recall of Benocten Tropfen zum Einnehmen Lösung highlights the importance of robust quality control measures and the need for transparency and communication in regulatory processes. Healthcare professionals and the public should remain vigilant and report any incidents related to the use of medicinal products.
This information is provided for awareness purposes only and should not be considered as medical or regulatory advice.
For full information about the Swissmedic announcement, see the link below.